…
Australis Capital Inc. operates as a cannabis company in the United States and internationally. The company was incorporated in 2018 and is based in Las Vegas, Nevada.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Public information on Australis Capital Inc (AUSAF), quoted on the OTC Pink market, is limited and does not provide a clear description of ongoing business activities. Because long-term growth drivers are not publicly documented, investors may view the company as a speculative, low-transparency exposure that could benefit only from asset realization, restructuring, or improved disclosure.
Key risks include lack of transparent financial reporting, extremely low trading liquidity typical of Pink-sheet listings, potential for significant share dilution or corporate inactivity, and uncertainty about operational continuity.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 | 2018-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 | 2018-03-31 |
| Income before tax | -0.05M | -0.03M | -23.34M | -4.17M | -0.04M |
| Minority interest | - | 5.39M | 5.39M | 5.39M | 5.39M |
| Net income | -0.05M | -0.03M | -23.34M | -4.17M | -0.04M |
| Selling general administrative | - | 0.01M | 13.65M | 4.00M | 0.00M |
| Selling and marketing expenses | - | 0.00M | 0.37M | 0.00M | - |
| Gross profit | 0.01M | -0.00M | 0.00M | 0.13M | 0.00M |
| Reconciled depreciation | - | - | 0.60M | 0.01M | - |
| Ebit | -0.02M | -0.01M | -12.85M | -3.02M | -0.00M |
| Ebitda | -0.02M | -0.01M | -12.25M | -3.01M | 0.05M |
| Depreciation and amortization | 0.00M | 0.00M | 0.60M | 0.01M | 0.05M |
| Non operating income net other | - | - | - | 0.00M | 0.00M |
| Operating income | -0.02M | -0.01M | -14.40M | -4.29M | -0.00M |
| Other operating expenses | 0.06M | 0.03M | 14.62M | 4.01M | 0.00M |
| Interest expense | 0.00M | 0.00M | 0.20M | 0.46M | 0.09M |
| Interest income | - | - | 0.94M | 0.28M | 0.05M |
| Net interest income | - | - | 0.74M | -0.18M | -0.04M |
| Extraordinary items | - | - | - | 0.00M | 0.00M |
| Non recurring | - | - | - | 0.00M | 0.00M |
| Other items | - | - | - | 0.00M | 0.00M |
| Income tax expense | 0.00M | 0.00M | 0.80M | 1.04M | 0.04M |
| Total revenue | 0.01M | 0.00M | 0.22M | 0.13M | 0.00M |
| Total operating expenses | 0.06M | 0.03M | 14.62M | 4.01M | 0.00M |
| Cost of revenue | 0.00M | 0.00M | 0.22M | 0.00M | 0.00M |
| Total other income expense net | -0.03M | -0.01M | -9.68M | -0.11M | 0.00M |
| Discontinued operations | - | - | - | 0.00M | 0.00M |
| Net income from continuing ops | - | - | -23.34M | -4.17M | -0.04M |
| Net income applicable to common shares | -50.09M | -25.26M | -23.34M | -4.17M | -0.04M |
| Preferred stock and other adjustments | - | - | - | 0.00M | 0.00M |
| Breakdown | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 | 2018-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 | 2018-03-31 |
| Total assets | 0.06M | 0.08M | 63.70M | 65.05M | 3.01M |
| Intangible assets | 0.03M | 0.01M | 14.78M | 3.46M | 0.00M |
| Other current assets | 1.50M | 16.96M | 0.71M | 0.71M | 0.00M |
| Total liab | 0.02M | 0.02M | 5.93M | 4.38M | 3.17M |
| Total stockholder equity | 0.03M | 0.05M | 57.77M | 60.67M | -0.16M |
| Deferred long term liab | - | - | - | 0.00M | 0.00M |
| Other current liab | 0.00M | 0.00M | 0.29M | 1.31M | 0.00M |
| Common stock | 0.03M | 0.10M | 74.65M | 56.31M | 0.00M |
| Capital stock | - | - | 74.65M | 56.31M | - |
| Retained earnings | - | -0.05M | -27.68M | -4.33M | -0.16M |
| Other liab | 4.65M | 6.90M | 1.45M | 2.74M | 0.00M |
| Good will | - | 0.02M | 0.59M | 0.59M | 0.00M |
| Other assets | 0.02M | 0.03M | 7.15M | 13.16M | 0.00M |
| Cash | 0.00M | 0.00M | 7.65M | 5.58M | 0.00M |
| Total current liabilities | 0.01M | 0.01M | 3.88M | 1.86M | 3.17M |
| Current deferred revenue | - | - | 1.47M | -0.14M | - |
| Net debt | -0.00M | -0.00M | -6.90M | -5.58M | 3.14M |
| Short term debt | - | - | 0.14M | 0.14M | 3.14M |
| Short long term debt | - | - | - | 0.00M | 3.14M |
| Short long term debt total | - | - | 0.75M | 0.75M | 3.14M |
| Other stockholder equity | -0.03M | -0.05M | -0.05M | -0.05M | 0.00M |
| Property plant equipment | 6.42M | 1.40M | 5.68M | 0.12M | 0.00M |
| Total current assets | 0.01M | 0.02M | 23.72M | 28.11M | 3.01M |
| Long term investments | - | - | 11.80M | 16.84M | 0.00M |
| Net tangible assets | -7.63M | 32.02M | 42.40M | 56.63M | -0.16M |
| Short term investments | - | 0.00M | 1.55M | 2.93M | 0.00M |
| Net receivables | 4.44M | 1.76M | 0.43M | 0.40M | 3.01M |
| Long term debt | - | - | - | 0.00M | 0.00M |
| Inventory | 0.00M | 0.00M | 13.37M | 18.50M | 0.00M |
| Accounts payable | 0.01M | 0.00M | 1.97M | 0.56M | 0.04M |
| Total permanent equity | - | - | - | 0.00M | 0.00M |
| Noncontrolling interest in consolidated entity | - | - | - | 0.00M | 0.00M |
| Temporary equity redeemable noncontrolling interests | - | - | - | 0.00M | 0.00M |
| Accumulated other comprehensive income | - | - | 0.53M | 0.33M | 0.00M |
| Additional paid in capital | - | - | - | 0.00M | 0.00M |
| Common stock total equity | - | - | - | 0.00M | 0.00M |
| Preferred stock total equity | - | - | - | 0.00M | 0.00M |
| Retained earnings total equity | - | - | - | 0.00M | 0.00M |
| Treasury stock | - | - | - | 0.00M | 0.00M |
| Accumulated amortization | - | - | - | 0.00M | 0.00M |
| Non currrent assets other | -0.04M | -0.03M | -0.03M | -0.02M | 0.00M |
| Deferred long term asset charges | - | - | - | 0.00M | 0.00M |
| Non current assets total | 0.04M | 0.03M | 39.98M | 36.94M | 0.00M |
| Capital lease obligations | - | - | 0.75M | 0.00M | 0.00M |
| Long term debt total | - | - | - | 0.00M | 0.00M |
| Breakdown | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 | 2018-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 | 2018-03-31 |
| Investments | - | 0.49M | -6.24M | -18.12M | -18.12M |
| Change to liabilities | 0.00M | 2.11M | 0.93M | 1.35M | 0.00M |
| Total cashflows from investing activities | 5.16M | -2.92M | -2.10M | -25.36M | -25.36M |
| Net borrowings | - | -0.20M | -0.13M | -0.13M | 0.00M |
| Total cash from financing activities | 0.01M | -0.00M | 2.27M | 52.39M | 0.00M |
| Change to operating activities | - | 0.53M | -0.58M | -0.44M | 0.09M |
| Net income | -0.05M | -0.03M | -23.34M | -4.17M | -0.04M |
| Change in cash | -0.00M | -0.01M | -8.18M | 5.58M | -0.00M |
| Begin period cash flow | 0.00M | 0.02M | 24.52M | 24.52M | 0.00M |
| End period cash flow | 0.00M | 0.00M | 16.33M | 5.58M | 24.52M |
| Total cash from operating activities | -0.01M | -0.01M | -8.32M | -2.81M | -0.00M |
| Issuance of capital stock | - | - | 0.00M | 48.63M | - |
| Depreciation | 0.00M | 0.00M | 0.60M | 0.01M | 0.01M |
| Other cashflows from investing activities | 5.16M | 5.16M | 5.34M | -5.34M | -5.34M |
| Dividends paid | - | - | - | 0.00M | 0.00M |
| Change to inventory | - | -0.00M | -0.74M | -0.28M | -0.74M |
| Change to account receivables | - | 0.00M | -0.03M | -0.24M | -0.05M |
| Sale purchase of stock | - | -0.00M | -0.00M | 0.00M | 0.00M |
| Other cashflows from financing activities | 0.01M | -0.00M | 2.40M | 3.76M | 0.50M |
| Change to netincome | 34.22M | 12.69M | 14.01M | 0.94M | 0.94M |
| Capital expenditures | 0.00M | 0.00M | 1.20M | 0.13M | 0.13M |
| Change receivables | - | - | - | 0.00M | 0.00M |
| Cash flows other operating | - | - | - | 0.00M | 0.00M |
| Exchange rate changes | - | - | - | 0.00M | 0.00M |
| Cash and cash equivalents changes | - | - | - | 0.00M | 0.00M |
| Change in working capital | - | -0.00M | 0.52M | 0.83M | 0.04M |
| Stock based compensation | 0.00M | 0.00M | 5.41M | 0.68M | - |
| Other non cash items | 0.03M | 0.02M | -1.63M | -1.42M | - |
| Free cash flow | -0.01M | -0.01M | -9.52M | -2.94M | -0.00M |
Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| MKKGY Merck KGaA ADR |
-0.01 0.03% |
33.66 | 21.25 | 14.93 | 3.10 | 2.14 | 3.60 | 12.98 |
| MKGAF MERCK Kommanditgesellschaft auf Aktien |
0.04 0.02% |
169.25 | 24.86 | 15.11 | 3.13 | 1.98 | 3.08 | 18.89 |
| TAK Takeda Pharmaceutical Co Ltd ADR |
0.90 4.50% |
20.91 | - | 10.96 | 0.01 | 1.20 | 2.94 | 23.11 |
| TKPHF Takeda Pharmaceutical Co. Ltd. |
4.03 10.61% |
42.00 | - | 10.66 | 0.01 | 1.16 | 2.94 | 23.11 |
Australis Capital Inc. operates as a cannabis company in the United States and internationally. The company was incorporated in 2018 and is based in Las Vegas, Nevada.
376 East Warm Springs Road, Las Vegas, NV, United States, 89119
800 898 0648
| Name | Title | Year Born |
|---|---|---|
| Mr. Terrance R. Booth | CEO & Director | 1965 |
| Mr. Jon Paul | Chief Financial Officer | NA |
| Dr. Jason Ronald Bradley Dyck Ph.D. | Chief Science Officer, Chairman of Scientific Advisory Board & Director | 1969 |
| Ms. Leah S. Bailey | Chief Bus. Devel. Officer | 1956 |
| Mr. Roger Sykes | Chief Operating Officer | NA |
| Mr. Brent Edwin Reuter | Sr. VP of Investor Relations & Strategy | 1967 |
| Mr. Paul E. Larsen | Gen. Counsel | NA |
| Mr. Marc Lakmaaker | Sr. VP of Communications & Capital Markets | NA |
| Mr. Fausto Aceituno Aceituno | Chief Marketing Officer | NA |
| Thomas Larssen | Pres of ALPS | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.